Mesenchymal stem cells to promote islet transplant survival
Author:
- 1 December 2016
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Organ Transplantation
- Vol. 21 (6) , 568-573
Abstract
Purpose of review Mesenchymal stromal cells (MSCs) are adult stromal cells with therapeutic potential in allogeneic islet transplantation for type 1 diabetes patients. The process of islet isolation alone has been shown to negatively impact islet survival and function in vivo. In addition, insults mediated by the instant blood-mediated inflammatory reaction, hypoxia, ischemia and immune response significantly impact the islet allograft post transplantation. MSCs are known to exert cytoprotective and immune modulatory properties and thus are an attractive therapeutic in this context. Herein, the recent progress in the field of MSC therapy in islet transplantation is discussed. Recent findings MSC can promote islet survival and function in vivo. Importantly, studies have shown that human MSC donors have differential abilities in promoting islet regeneration/survival. Recently, several biomarkers associated with MSC islet regenerative capacity have been identified. Expressions of Annexin A1, Elastin microfibril interface 1 and integrin-linked protein kinase are upregulated in MSC displaying protective effects on islet survival and function in vivo. Summary The discovery of biomarkers associated with MSC therapeutic efficacy represents an important step forward for the utilization of MSC therapy in islet transplantation; however, much remains to be elucidated about the mechanisms utilized by MSC in protection against transplanted islet loss, autoimmune-mediated and alloimmune-mediated rejection.Keywords
This publication has 45 references indexed in Scilit:
- Brief Report: Elastin Microfibril Interface 1 and Integrin-Linked Protein Kinase Are Novel Markers of Islet Regenerative Function in Human Multipotent Mesenchymal Stromal CellsStem Cells, 2016
- Targeting Homeostatic T Cell Proliferation to Control Beta-Cell AutoimmunityCurrent Diabetes Reports, 2016
- Co-combination of islets with bone marrow mesenchymal stem cells promotes angiogenesisBiomedicine & Pharmacotherapy, 2016
- Transplantation of mesenchymal stem cells improves type 1 diabetes mellitusCell and tissue research, 2015
- Novel immunological strategies for islet transplantationPharmacological Research, 2015
- Mesenchymal Stem Cell Modulates T Follicular Helper Cell to Induce Immunotolerance of Islet AllograftTransplantation Proceedings, 2015
- Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged siteActa Diabetologica, 2015
- Concise review: Adult mesenchymal stromal cell therapy for inflammatory diseases: How well are we joining the dots?Stem Cells, 2013
- Pre-culturing islets with mesenchymal stromal cells using a direct contact configuration is beneficial for transplantation outcome in diabetic miceCytotherapy, 2013
- Co-transplantation of mesenchymal stem cells maintains islet organisation and morphology in miceDiabetologia, 2011